top of page
Search

Autoimmune Hepatitis vs PBC vs PSC — MRCP Part 1

TL;DR:

For MRCP Part 1, differentiating autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC) relies on recognising patterns: hepatocellular vs cholestatic LFTs, key antibodies, and hallmark associations. AIH presents with raised transaminases and ANA/SMA positivity; PBC with AMA and pruritus; PSC with IBD and “beading” on MRCP. Focus on patterns, not isolated facts.


Why this matters

Autoimmune liver diseases are consistently tested in MRCP Part 1, often through subtle clinical vignettes rather than direct recall. Candidates commonly confuse PBC and PSC or miss autoimmune hepatitis when it mimics viral disease.

These topics integrate immunology, hepatology, and clinical reasoning, making them high-yield across multiple question formats. A strong grasp here significantly improves accuracy in lab interpretation and case-based MCQs.

For a structured roadmap, see the MRCP Part 1 overview:👉 https://www.crackmedicine.co.uk/mrcp-part-1/


Core Concepts You Must Master

1. Pattern Recognition (Most Tested Concept)

Feature

Autoimmune Hepatitis (AIH)

PBC

PSC

LFT pattern

Hepatocellular (↑ALT/AST)

Cholestatic (↑ALP)

Cholestatic (↑ALP)

Antibodies

ANA, SMA

AMA (highly specific)

p-ANCA (non-specific)

Demographics

Young women

Middle-aged women

Young men

Associations

Autoimmune diseases

Sjögren’s, thyroid disease

Ulcerative colitis

Imaging

Usually normal

Normal early

“Beading” on MRCP

Cancer risk

HCC (via cirrhosis)

Low

Cholangiocarcinoma

👉 Exam rule:

  • ↑ALT/AST → think AIH

  • ↑ALP → think PBC or PSC

2. Autoimmune Hepatitis (AIH)

  • Young female predominance

  • Marked transaminase elevation

  • ↑IgG (hypergammaglobulinaemia)

  • Positive ANA / anti-smooth muscle antibody

  • Can mimic acute viral hepatitis

Treatment: Steroids ± azathioprine

👉 Classic trap: Viral hepatitis picture but negative serology + positive autoantibodies

3. Primary Biliary Cholangitis (PBC)

  • Middle-aged women

  • Cholestatic LFTs (↑ALP)

  • Strong AMA positivity

  • Symptoms: pruritus, fatigue

  • Associated with Sjögren’s syndrome

Treatment: Ursodeoxycholic acid

👉 Key clue: Pruritus + AMA = PBC

4. Primary Sclerosing Cholangitis (PSC)

  • Young men

  • Strong link with ulcerative colitis

  • Cholestatic LFTs

  • MRCP: “beading” of bile ducts

Complications:

  • Cholangiocarcinoma (very high yield)

  • Colorectal cancer

👉 Key clue: PSC = IBD + beaded ducts

5. Small vs Large Duct Disease

  • PBC → small intrahepatic ducts

  • PSC → intra + extrahepatic ducts

👉 Explains why:

  • PSC → abnormal MRCP

  • PBC → often normal imaging early

6. Immunology Pearls

  • AIH → ↑IgG

  • PBC → ↑IgM

  • PSC → no specific immunoglobulin

7. Overlap Syndromes

Occasionally tested:

  • AIH–PBC overlap

  • AIH–PSC overlap

👉 If features don’t fit neatly → consider overlap

8. Cancer Associations

  • PSC → cholangiocarcinoma

  • AIH → cirrhosis → HCC

  • PBC → lower malignancy risk

9. First-Line Investigations

  • AIH → autoantibodies + IgG

  • PBC → AMA

  • PSC → MRCP

10. Treatment Differences

  • AIH → immunosuppression

  • PBC → ursodeoxycholic acid

  • PSC → transplant in advanced disease

Medical student studying hepatology for MRCP Part 1 with notes and revision materials

Practical Example (MRCP-style MCQ)

Question: A 32-year-old man with ulcerative colitis presents with fatigue and pruritus. Blood tests show markedly elevated ALP. MRCP reveals irregular narrowing and dilatation of bile ducts.

What is the diagnosis?

A. Autoimmune hepatitisB. Primary biliary cholangitisC. Primary sclerosing cholangitisD. Viral hepatitisE. Drug-induced liver injury

Answer: C. Primary sclerosing cholangitis

Explanation:

  • Male + ulcerative colitis → PSC

  • Cholestatic LFTs (↑ALP)

  • MRCP “beading” → diagnostic

👉 Classic integration question in MRCP Part 1


Common Pitfalls (Top 5)

  • Confusing PBC vs PSC (AMA vs IBD association)

  • Missing AIH in acute presentations

  • Forgetting PSC → cholangiocarcinoma risk

  • Assuming imaging is always abnormal in cholestatic disease

  • Ignoring IgG vs IgM patterns


Practical Study Checklist

  1. Classify LFTs first (hepatocellular vs cholestatic)

  2. Memorise one antibody per disease

  3. Link disease with demographics

  4. Use associations:

    • AIH → autoimmune

    • PBC → Sjögren’s

    • PSC → ulcerative colitis

  5. Practise questions via:


    👉 https://www.crackmedicine.co.uk/qbank/

  6. Simulate exam conditions:


    👉 https://www.crackmedicine.co.uk/mock-tests/

👉 Suggested companion reading: Abnormal LFT interpretation (hepatology core topic)


FAQs

1. How do I differentiate PBC and PSC quickly?

PBC: middle-aged woman + AMA.PSC: young man + ulcerative colitis + MRCP changes.

2. Which disease has antimitochondrial antibodies?

Primary biliary cholangitis (PBC). It is highly specific and frequently tested.

3. What is the hallmark imaging finding in PSC?

“Beading” of bile ducts on MRCP due to alternating strictures and dilatations.

4. Which condition is treated with steroids?

Autoimmune hepatitis (AIH), typically with azathioprine as maintenance.

5. Which has the highest cancer risk?

PSC, due to strong association with cholangiocarcinoma.


Ready to start?

Build exam confidence with structured preparation. Start with the full MRCP Part 1 overview:👉 https://www.crackmedicine.co.uk/mrcp-part-1/

Then reinforce learning with targeted practice:

Consistency and pattern recognition are key to success.


Sources

 
 
 

Comments

bottom of page